Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
0.010 Biomarker disease BEFREE A significant increase in the renal function markers (BUN, 240%; creatinine, 187%; and creatine kinase, 117%), oxidative stress parameters (lipid peroxidation, 192% increase; catalase, 30.5% decrease), cytokines (IL-4, 120%; TNF-<i>α</i>, 129%; and IFN-<i>γ</i>, 133%), and DNA damage was observed in the TAA-treated group. 31583036 2019
Entrez Id: 4015
Gene Symbol: LOX
LOX
0.330 Biomarker disease BEFREE Lysyl oxidase is shown to protect against AA formation. 31554420 2019
Entrez Id: 2159
Gene Symbol: F10
F10
0.030 Biomarker disease BEFREE This exploratory analysis of NAVIGATE ESUS (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial Versus ASA to Prevent Embolism in Embolic Stroke of Undetermined Source) focused on patients with AAA and assessed their characteristics, stroke recurrence rates, and response to treatment. 31526123 2019
Entrez Id: 7249
Gene Symbol: TSC2
TSC2
0.010 GeneticVariation disease BEFREE Congenital Lymphatic Malformation and Aortic Aneurysm in a Patient with TSC2 Mutation. 31505689 2020
Entrez Id: 10516
Gene Symbol: FBLN5
FBLN5
0.110 Biomarker disease BEFREE In summary, using weighted gene coexpression analysis, our study indicates that CLU, DES, MYH10, and FBLN5 were identified and validated to be related to TAA and might be candidate biomarkers or therapeutic targets for TAA. 31489966 2020
Entrez Id: 4628
Gene Symbol: MYH10
MYH10
0.010 Biomarker disease BEFREE In summary, using weighted gene coexpression analysis, our study indicates that CLU, DES, MYH10, and FBLN5 were identified and validated to be related to TAA and might be candidate biomarkers or therapeutic targets for TAA. 31489966 2020
Entrez Id: 4016
Gene Symbol: LOXL1
LOXL1
0.010 AlteredExpression disease BEFREE Therefore, LOXL1-AS was up-regulated in TAA and regulated proliferation and apoptosis of LOXL1-AS by up-regulating Giver. 31471532 2019
Entrez Id: 693159
Gene Symbol: MIR574
MIR574
0.010 AlteredExpression disease BEFREE MiR-574-5p serum levels discriminated TAA patients from controls with an area under the receiver operating characteristic curve of 0.87. 31409059 2019
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.010 AlteredExpression disease BEFREE Additionally, higher adiponectin levels and IDO activity were observed in FMF-related AAA compared with FMF without AAA (p<0.05). 31377728 2019
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.020 Biomarker disease BEFREE In TAA-treated OVX rats, the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and γ-glutamyl transferase (GGT) were significantly increased compared to those in TAA-treated sham-operated OVX rats or TAA-treated male rats. 31362375 2019
Entrez Id: 847
Gene Symbol: CAT
CAT
0.020 AlteredExpression disease BEFREE In addition, ED markedly reduced total glutathione (GSH) levels, as well as catalase (CAT) and superoxide dismutase (SOD) activity in TAA-treated OVX rats. 31362375 2019
Entrez Id: 7431
Gene Symbol: VIM
VIM
0.010 Biomarker disease BEFREE This was accompanied by the appearance of fibrosis biomarkers including vimentin, collagen-I, and hydroxyproline, in the liver of TAA-treated OVX rats. 31362375 2019
Entrez Id: 100750246
Gene Symbol: HIF1A-AS1
HIF1A-AS1
0.040 Biomarker disease BEFREE It is now emerging that long noncoding RNAs (lncRNAs) play key regulatory roles in these adverse responses: lncRNA TUG1, AK098656, TRPV1, GAS5, Giver, and Lnc-Ang362 have been indicated in hypertension-related vascular remodeling, H19, TUG1, UCA1, MEG3, APPAT, and lincRNA-p21 in atherosclerosis (AS), and HIF1A-AS1 and Lnc-HLTF-5 in aortic aneurysm (AA). 31355277 2019
Entrez Id: 102800311
Gene Symbol: TP53COR1
TP53COR1
0.020 Biomarker disease BEFREE It is now emerging that long noncoding RNAs (lncRNAs) play key regulatory roles in these adverse responses: lncRNA TUG1, AK098656, TRPV1, GAS5, Giver, and Lnc-Ang362 have been indicated in hypertension-related vascular remodeling, H19, TUG1, UCA1, MEG3, APPAT, and lincRNA-p21 in atherosclerosis (AS), and HIF1A-AS1 and Lnc-HLTF-5 in aortic aneurysm (AA). 31355277 2019
Entrez Id: 104457406
Gene Symbol: MIR222HG
MIR222HG
0.010 Biomarker disease BEFREE It is now emerging that long noncoding RNAs (lncRNAs) play key regulatory roles in these adverse responses: lncRNA TUG1, AK098656, TRPV1, GAS5, Giver, and Lnc-Ang362 have been indicated in hypertension-related vascular remodeling, H19, TUG1, UCA1, MEG3, APPAT, and lincRNA-p21 in atherosclerosis (AS), and HIF1A-AS1 and Lnc-HLTF-5 in aortic aneurysm (AA). 31355277 2019
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.200 Biomarker disease BEFREE Taking into consideration the continuously ongoing challenges during life, there is a physiological degradation of elastin into elastin-derived peptides which is accentuated in several disease states such as obstructive pulmonary diseases, atherosclerosis and aortic aneurysm. 31295577 2019
Entrez Id: 183
Gene Symbol: AGT
AGT
0.400 Biomarker disease BEFREE In an angiotensin II (Ang II)-induced mouse aortic aneurysm (AA) model, PTENP1 overexpression potentiated aortic SMC apoptosis, exacerbated aneurysm formation. 31235554 2019
Entrez Id: 11191
Gene Symbol: PTENP1
PTENP1
0.010 AlteredExpression disease BEFREE In an angiotensin II (Ang II)-induced mouse aortic aneurysm (AA) model, PTENP1 overexpression potentiated aortic SMC apoptosis, exacerbated aneurysm formation. 31235554 2019
Entrez Id: 101243555
Gene Symbol: PTENP1-AS
PTENP1-AS
0.010 Biomarker disease BEFREE Our study identified PTENP1 as a mediator of HASMC homeostasis and suggests that PTENP1 is a potential target in AD or AA intervention. 31235554 2019
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1
0.010 Biomarker disease BEFREE Due to the association with autoimmune diseases and proven application in population genetics, we aimed to investigate alleles of the Class II Human Leukocyte Antigens (HLA-DRB1) in the Mexican Mestizo population with aortic aneurysms and determine possible associations with susceptibility. 31174489 2019
Entrez Id: 2200
Gene Symbol: FBN1
FBN1
0.200 GeneticVariation disease BEFREE Marfan syndrome (MFS) is associated with mutations in fibrillin-1 that predispose afflicted individuals to progressive thoracic aortic aneurysm (TAA) leading to dissection and rupture of the vessel wall. 31167969 2019
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.010 GeneticVariation disease BEFREE Rats in the TAA-treated group received either a chow diet (Control group) or a chow diet containing MS (TMS group, 2.05%) or silymarin (TSM group, 0.05%). 31151157 2019
Entrez Id: 29108
Gene Symbol: PYCARD
PYCARD
0.010 GeneticVariation disease BEFREE Rats in the TAA-treated group received either a chow diet (Control group) or a chow diet containing MS (TMS group, 2.05%) or silymarin (TSM group, 0.05%). 31151157 2019
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.200 Biomarker disease BEFREE Aortic diameter in the DM+AA group was less than that in the AA group, and elastin fragmentation grade of the aortic wall was reduced in the DM+AA group. 31096818 2019
Entrez Id: 1471
Gene Symbol: CST3
CST3
0.010 Biomarker disease BEFREE More cathepsin L-positive cells were observed in the AA group than in the DM+AA group; conversely, more cystatin C-positive cells were observed in the DM+AA group than in the AA group. 31096818 2019